16 results
8-K
EX-10.1
INVA
Innoviva Inc
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
only information that is generally known and used by persons with training and experience comparable to my own, is common knowledge in the industry
SC TO-T
EX-99
LJPC
La Jolla Pharmaceutical Co.
25 Jul 22
Third party tender offer statement
8:34am
of the education and training programs at Rockefeller University Center for Clinical and Translational Science and serves on the Medical Staff Executive
SC TO-T
EX-99
7ku266vjqi28 jfb8
7 Jun 22
Third party tender offer statement
9:04am
8-K
EX-10.1
2fzxwepqmdj63dfm u4m
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.4
4m639vc jz
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K/A
EX-10.2
nog92 ewh75yydvm2qp
6 Mar 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.2
dgyrbxnoh9cne5
10 Sep 13
Other Events
12:00am
S-3ASR
EX-10.1
bb5nzcfi r2he1ro
30 Jan 06
Automatic shelf registration
12:00am
- Prev
- 1
- Next